0002108969-26-000001.txt : 20260203 0002108969-26-000001.hdr.sgml : 20260203 20260203124004 ACCESSION NUMBER: 0002108969-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260203 DATE AS OF CHANGE: 20260203 EFFECTIVENESS DATE: 20260203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Starget Pharma Inc. CENTRAL INDEX KEY: 0002108969 ORGANIZATION NAME: EIN: 413053045 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-572220 FILM NUMBER: 26591343 BUSINESS ADDRESS: STREET 1: 2031 KINGS HIGHWAY CITY: SHREVEPORT STATE: LA ZIP: 71103 BUSINESS PHONE: 318-746-8430 MAIL ADDRESS: STREET 1: 2031 KINGS HIGHWAY CITY: SHREVEPORT STATE: LA ZIP: 71103 D 1 primary_doc.xml X0708 D LIVE 0002108969 Starget Pharma Inc. 2031 KINGS HIGHWAY SHREVEPORT LA LOUISIANA 71103 318-746-8430 DELAWARE None None Corporation true 2025 Sigal Kalmanson Cusnir Hailanot 112 Tzofit L3 ISRAEL 4492500 Executive Officer Ronen Kalmanson Snir 26 Ramat Hasharon L3 ISRAEL 4704087 Director Biotechnology Decline to Disclose 06b false 2026-01-20 false true false 50000 22158515 16373737 5784778 Amount includes conversion of $12,373,737 in SAFEs. false 29 0 0 0 false Starget Pharma Inc. /s/ Sigal Kalmanson Cusnir Sigal Kalmanson Cusnir CEO 2026-02-03